FTC sues Shire ViroPharma for delaying generic competition

The Federal Trade Commission sued Shire ViroPharma for violating antitrust laws by abusing government processes to delay competition for its Vancocin capsules. The agency alleged that the company waged a campaign of 46 serial, repetitive, and unsupported filings with the Food and Drug Administration and the courts. These “repetitive, serial,